NPR Health reports: All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
lifestyle | health | NPR Health | June 19, 2026 12:43 AM
Key FDA committee unanimously recommends its first vaccine since 2023
All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.
Source attribution
This PeeDeeWire article is based on reporting from NPR Health and links readers to the original source for full context.
Read the original source report